Monthly Cannabis Use Didn't Undermine Anxiety and Depression Treatment in This Clinical Trial
Occasional cannabis users responded just as well to combined CBT and medication treatment for anxiety and depression as non-users.
Quick Facts
What This Study Found
In a randomized trial of 232 adults with anxiety and panic disorders, researchers examined whether occasional cannabis use affected treatment outcomes.
Participants receiving a combined cognitive-behavioral therapy (CBT) and medication intervention showed similar improvements in anxiety regardless of cannabis use frequency. Monthly cannabis users' anxiety outcomes were comparable to those who used less frequently.
For depression specifically, monthly cannabis users in the active treatment group improved just as much as less frequent users. However, monthly users who received only usual care had significantly worse depressive symptoms than their less-frequent-using counterparts, suggesting the structured intervention may have been particularly beneficial for cannabis users.
Key Numbers
232 adults participated. Monthly cannabis users in usual care had significantly more depressive symptoms than less-than-monthly users. In the CCAP intervention group, no significant difference by cannabis use frequency.
How They Did This
This was a secondary analysis of the Collaborative Care for Anxiety and Panic (CCAP) study, a randomized effectiveness trial at six university-based primary care clinics. 232 adults were randomized to either the CCAP intervention (combined CBT and pharmacotherapy) or usual care. Cannabis use frequency was assessed and used as a moderating variable.
Why This Research Matters
Clinicians often worry that cannabis use undermines mental health treatment. This study found the opposite pattern for depression: cannabis users benefited from structured treatment at least as much as non-users, while those receiving only usual care fared worse if they used cannabis monthly.
The Bigger Picture
This study contributed to the clinical conversation about whether to exclude or discourage cannabis-using patients from standard mental health treatments. The findings suggest that combined CBT and medication approaches may work well regardless of occasional cannabis use.
What This Study Doesn't Tell Us
Cannabis use was self-reported and categorized broadly (monthly vs. less than monthly). The study was not designed or powered specifically to test cannabis use as a moderating variable. The relatively small sample limits subgroup analyses.
Questions This Raises
- ?Would daily or heavy cannabis use show different patterns?
- ?Does cannabis use interact differently with specific types of anxiety disorders or specific medications?
Trust & Context
- Key Stat:
- Cannabis users responded equally well to combined CBT + medication treatment
- Evidence Grade:
- This is a randomized controlled trial, but cannabis use was analyzed as a secondary moderating variable rather than the primary outcome, and the sample was relatively small for subgroup analysis.
- Study Age:
- Published in 2007. More recent research has continued to explore cannabis-mental health treatment interactions with mixed findings.
- Original Title:
- Does occasional cannabis use impact anxiety and depression treatment outcomes?: Results from a randomized effectiveness trial.
- Published In:
- Depression and anxiety, 24(6), 392-8 (2007)
- Authors:
- Bricker, Jonathan B, Russo, Joan, Stein, Murray B(4), Sherbourne, Cathy, Craske, Michelle, Schraufnagel, Trevor J, Roy-Byrne, Peter
- Database ID:
- RTHC-00266
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
Does this mean cannabis helps with anxiety treatment?
No. The study found that occasional cannabis use didn't interfere with treatment, not that cannabis itself contributed to improvement. The treatment worked despite cannabis use, not because of it.
What was the CCAP intervention?
It combined cognitive-behavioral therapy (CBT) with medication management, delivered through a collaborative care model in primary care settings, for patients with anxiety and panic disorders.
Read More on RethinkTHC
- anxiety-leaving-house-weed-withdrawal-agoraphobia
- anxiety-response-technique-weed-withdrawal
- anxiety-toolkit-weed-withdrawal
- anxiety-worse-after-quitting-weed
- breathing-exercises-weed-withdrawal-anxiety
- cannabis-induced-anxiety
- does-weed-help-anxiety
- grounding-techniques-weed-withdrawal
- health-anxiety-weed-withdrawal
- manage-anxiety-without-weed
- quitting-weed-anxiety-disorder
- quitting-weed-anxiety-medication-ssri
- self-medicating-anxiety-with-weed
- therapy-quitting-weed-anxiety
- weed-and-anxiety
- weed-biphasic-effect-anxiety
- weed-generalized-anxiety-disorder
- weed-panic-attacks
- weed-paranoia
- weed-social-anxiety
- weed-tolerance-anxiety-stopped-working
- weed-withdrawal-anxiety
- weed-withdrawal-panic-attacks-night
- weed-withdrawal-work-anxiety
- withdrawal-anxiety-vs-real-anxiety
- why-does-weed-make-you-paranoid-amygdala
- why-weed-makes-me-anxious-now-not-before
- thc-and-ssris-cannabis-antidepressants
- thc-and-benzodiazepines-dangerous-overlap
- cannabis-and-socializing-only-use-around-others
Cite This Study
https://rethinkthc.com/research/RTHC-00266APA
Bricker, Jonathan B; Russo, Joan; Stein, Murray B; Sherbourne, Cathy; Craske, Michelle; Schraufnagel, Trevor J; Roy-Byrne, Peter. (2007). Does occasional cannabis use impact anxiety and depression treatment outcomes?: Results from a randomized effectiveness trial.. Depression and anxiety, 24(6), 392-8.
MLA
Bricker, Jonathan B, et al. "Does occasional cannabis use impact anxiety and depression treatment outcomes?: Results from a randomized effectiveness trial.." Depression and anxiety, 2007.
RethinkTHC
RethinkTHC Research Database. "Does occasional cannabis use impact anxiety and depression t..." RTHC-00266. Retrieved from https://rethinkthc.com/research/bricker-2007-does-occasional-cannabis-use
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.